Pan X, Solomon S S, Borromeo D M, Martinez-Hernandez A, Raghow R
Research, Medical, and Pathology Services, Veterans Affairs Medical Center of Memphis, University of Tennessee, Memphis, Tennessee 38104, USA.
Endocrinology. 2001 Apr;142(4):1635-42. doi: 10.1210/endo.142.4.8083.
Members of the family of Sp transcription factors include Sp1, Sp3, and Sp4 and are important regulators of eukaryotic gene expression. We previously reported that Sp1 mediated stimulation of rat calmodulin I gene expression in response to insulin. To test whether other members of the Sp family are direct targets of insulin action, we compared the levels of Sp1 and Sp3 proteins from nuclear extracts obtained from both insulin-treated and untreated rat hepatoma (H-411E) cells. We demonstrated by Western blot analysis that levels of Sp1 and Sp3 proteins were increased more than 2-fold in the insulin-treated group. Additionally, the up-regulation of both Sp1 and Sp3 transcription factors by insulin was antagonized by tumor necrosis factor-alpha, a known inhibitor of insulin action. Immunohistochemical analysis demonstrated that H-411E cells treated with insulin (10,000 microU/ml) had a marked increase in demonstrable Sp1 in the nucleus compared with cells incubated in insulin-free medium. We extended these in vitro observations to in vivo studies in the streptozotocin-diabetic rat model. We demonstrated in rat liver tissue by both Western blot and immunohistochemical staining with anti-Sp1 antibody that 1) livers of fully diabetic streptozotocin rats have low levels of Sp1 transcription factor; and 2) insulin treatment of the diabetic rat rapidly reversed this process by markedly stimulating accumulation of Sp1 in rat liver. Studies of the signal transduction mechanisms involved in insulin's effect on Sp1 demonstrate a facilitating role for phosphoinositol 3-kinase and an inhibitory role for cyclic nucleotides. In summary, insulin stimulates Sp1 protein, a transcription factor that is shown to regulate calmodulin gene expression and most likely other, as yet untested, genes.
Sp转录因子家族成员包括Sp1、Sp3和Sp4,是真核基因表达的重要调节因子。我们之前报道过Sp1介导了大鼠钙调蛋白I基因表达对胰岛素的应答。为了检测Sp家族的其他成员是否是胰岛素作用的直接靶点,我们比较了胰岛素处理组和未处理组大鼠肝癌(H-411E)细胞核提取物中Sp1和Sp3蛋白的水平。我们通过蛋白质免疫印迹分析证明,胰岛素处理组中Sp1和Sp3蛋白的水平增加了两倍多。此外,胰岛素对Sp1和Sp3转录因子的上调作用被肿瘤坏死因子-α(一种已知的胰岛素作用抑制剂)所拮抗。免疫组织化学分析表明,与在无胰岛素培养基中培养的细胞相比,用胰岛素(10,000微单位/毫升)处理的H-411E细胞核中可检测到的Sp1显著增加。我们将这些体外观察结果扩展到链脲佐菌素诱导的糖尿病大鼠模型的体内研究。我们通过蛋白质免疫印迹和抗Sp1抗体免疫组织化学染色在大鼠肝脏组织中证明:1)完全糖尿病的链脲佐菌素大鼠肝脏中Sp1转录因子水平较低;2)对糖尿病大鼠进行胰岛素治疗可通过显著刺激大鼠肝脏中Sp1的积累迅速逆转这一过程。对胰岛素影响Sp1的信号转导机制的研究表明,磷酸肌醇3激酶起促进作用,环核苷酸起抑制作用。总之,胰岛素刺激Sp1蛋白,Sp1是一种转录因子,已证明其可调节钙调蛋白基因表达,很可能还调节其他尚未测试的基因。